宜曼达 ILMN 深 沪
等待开盘 02-05 09:30:00 美东时间
134.19
-1.240
-0.92%
华盛通- 最 高140.6499
- 今 开137.10
- 成交量 293.63万股
- 最 低 133.33
- 昨 收 135.43
- 总市值 205.31亿
- 52周最高 155.529
- 市盈率 静 --
- 换手率 1.92%
- 52周最低 68.70
- 委 比 -81.24%
- 总股本 1.53亿
- 历史最高 552.665
- 量 比 1.32
- 振 幅 5.40%
- 历史最低 22.465
- 每 手 1
- 风险率 21.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Olympics-Figure skating-Guarino Sabate given green light to use Minions music
Olympics-Figure skating-Guarino Sabate given green light to use Minions music By Lori Ewing MILAN, Feb 3 (Reuters) - Spanish figure skater Tomas-Llorenc Guarino Sabate said he will be allowed to use music from the "Minions" film franchise when he competes in the men's short programme after Universa
02-04 01:14
Illumina Announces Sequencing Agreement With San Diego Zoo Wildlife Alliance's Frozen Zoo
Sequencing connects decades of preserved biodiversity with the latest multiomic technologiesSAN DIEGO, Feb. 3, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced a sequencing agreement with the San
02-03 22:17
PacBio Completes Sale of Short-Read Sequencing Assets
PacBio completed the sale of certain intellectual property and assets related to its short-read DNA sequencing technology to Illumina, receiving $48.1 million in net cash proceeds. The transaction strengthens PacBio's focus on its long-read sequencing platform and enables the acceleration of SPRQ-Nx chemistry development for comprehensive and competitively priced genome analysis.
02-02 14:05
Standard BioTools Completes Sale Of SomaLogic To Illumina For Up To $425M Plus Royalties
Received $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout paymentsApproximately $550 Million in cash & cash equivalents on balance sheet at close, excluding
01-30 22:14
Illumina completes acquisition of SomaLogic
Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein analysis Combination leverages SomaScan with...
01-30 22:05
Standard BioTools Completes Sale of SomaLogic to Illumina
Standard BioTools completed the sale of SomaLogic to Illumina for $350 million upfront, plus up to $75 million in earnouts and royalties. The transaction enhances the company's financial position, with $550 million in cash to fuel M&A growth. CEO Michael Egholm highlighted the strategic transformation and strengthened financial standing. The deal includes IP licenses and royalty streams, positioning the company for future expansion.
01-30 14:09
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
The Analyst Verdict: Illumina In The Eyes Of 15 Experts
Throughout the last three months, 15 analysts have evaluated Illumina (NASDAQ:I...
01-27 06:00
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies Jan 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CACI International, First Citizens Bancshares and Teledyne Technologies, o
01-26 15:22
美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
